|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/4188 | (2006.01) |
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3273957 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16713833.8 |
| Date of filing the European patent application | 2016-03-25 | |
| (97) | Date of publication of the European application | 2018-01-31 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-14 |
| (46) | Date of publication of the claims translation | 2019-11-11 |
| (86) | Number | PCT/EP2016/056696 |
| Date | 2016-03-25 |
| (87) | Number | WO 2016/151132 |
| Date | 2016-09-29 |
| (30) | Number | Date | Country code |
| 15305437 | 2015-03-26 | EP |
| (72) |
SEDEL, Frédéric, FR
|
| (73) |
Medday Pharmaceuticals,
24/26 rue de la Pépiniere, 75008 Paris,
FR
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Biotinas, skirtas demielinizuojančių neuropatijų gydymui |
| BIOTIN FOR TREATING DEMYELINATING NEUROPATHIES |
| Payment date | Validity (years) | Amount | |
| 2022-02-17 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-03-25 |